Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Journalists

RevitaLash® Cosmetics Introduces RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, a Revolutionary Lash Serum Made without Prostaglandin Analogues

This image opens in the lightbox

News provided by

RevitaLash Cosmetics

29 Sep, 2026, 13:01 GMT

Share this article

Share toX

Share this article

Share toX

Ophthalmologist-developed and clinically tested, the new peptide-powered formula pairs advanced time-release technology with high-performance lash conditioning

VENTURA, Calif., Sept. 29, 2026 /PRNewswire/ -- RevitaLash® Cosmetics, the internationally recognized leader in lash, brow, and hair care, is advancing lash innovation once again with the launch of RevitaLash Peptide Complex+ Time Release Eyelash Conditioner, the world's first time-release multi-peptide lash conditioning serum developed by an ophthalmologist.

Continue Reading
This image opens in the lightbox
RevitaLash Peptide Complex+ Time Release Eyelash Conditioner

Scientifically advanced and clinically tested, the new formula offers a high-performance approach to lash conditioning for consumers seeking the look of stronger, healthier, more bold and resilient lashes without the use of prostaglandins.

At the heart of the formula is RevitaLash Peptide Complex, featuring Revitasome® Technology, Troxerutin and MP17, which combines a protective antioxidant with a biomimetic signal peptide in a time-release liposomal delivery system. Designed to release over eight hours for gentle, optimal absorption into the eyelashes, the peptide-dense, nutrient-rich formula helps support the appearance of natural lash volume while reinforcing strength to help decrease the appearance of fallout and breakage. The result: lashes that look shinier, stronger, more flexible and beautifully conditioned.

"We are proud of this first-of-its kind expansion to our lash serum collection with a formula that brings together advanced science and innovative time-release technology to meet the evolving needs of today's consumer," said Lori Jacobus, President and Global CMO of RevitaLash® Cosmetics. "RevitaLash Peptide Complex+ offers a new way to achieve the look of stronger, healthier, beautifully conditioned lashes while delivering the performance, innovation and expertise consumers have come to expect from RevitaLash Cosmetics."

In a 12-week consumer study of 160 users, RevitaLash Peptide Complex+ delivered visible improvements in the appearance and condition of lashes. After just six weeks, 90% of participants reported improved lash appearance and 90% reported healthier-looking lashes. Additionally, 89% saw enhanced lash appearance at six weeks, increasing to 92% at 12 weeks, while 89% felt their lashes were more nourished at six weeks, increasing to 96% at 12 weeks.

The launch expands RevitaLash Cosmetics' trusted portfolio of lash conditioners, joining RevitaLash® Advanced, RevitaLash® Advanced Sensitive and RevitaLash® Advanced Pro Eyelash Conditioner, and giving consumers even more choice within the brand's science-backed lash care collection.

RevitaLash Peptide Complex+ is ophthalmologist-developed, dermatologist-reviewed, hypoallergenic, non-irritating, vegan-friendly and cruelty-free. The formula is also made without parabens, phthalates, gluten, oil and prostaglandin analogues.

RevitaLash Peptide Complex+ Time Release Eyelash Conditioner (4.0 mL / 0.135 fl. oz.) retails for a suggested price of $90.00 and will be available globally beginning 1 October 2026 through authorized salons, spas, specialty retailers and revitalash.com.

About RevitaLash® Cosmetics

RevitaLash Cosmetics is a worldwide leader in developing premium advanced lash, brow and hair beautification products. Founded in 2006 by ophthalmologist Michael Brinkenhoff, M.D., the brand was inspired by his desire to help his wife feel beautiful during her battle with breast cancer. Today, RevitaLash Cosmetics is available in more than 70 countries and is recognized globally for its award-winning products, leading innovation, commitment to safety and its give-back mission supporting breast cancer initiatives through its longstanding Eternally Pink® pledge that has contributed over $14 million to date.

Modal title

Also from this source

RevitaLash® Cosmetics Celebrates 14th Consecutive Allure Best of Beauty Win

RevitaLash® Cosmetics Celebrates 14th Consecutive Allure Best of Beauty Win

For the 14th consecutive year, RevitaLash® Cosmetics has received the esteemed Allure Best of Beauty Award for "Best Brow Conditioner" recognizing...

RevitaLash® Cosmetics Launches 5-in-1 Leave-In Hair Mask & Conditioner

RevitaLash® Cosmetics Launches 5-in-1 Leave-In Hair Mask & Conditioner

RevitaLash® Cosmetics, the internationally recognized leader in lash, brow, and hair care, announces the exciting launch of its new Leave-In Hair...

More Releases From This Source

Explore

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

Medical Pharmaceuticals

Medical Pharmaceuticals

Retail

Retail

Hispanic

Hispanic

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content

About

  • About PR Newswire
  • About Cision
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.